Loading
Life sciences · Review
Current Allergy and Asthma Reports · November 4, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Review.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
This review examines asthma in older adults over the past decade, focusing on epidemiology, diagnostic challenges, and current management. It also explores why asthma remains underdiagnosed and undertreated in this population. Asthma prevalence is increasing among older adults worldwide, particularly in developed regions and Asia, yet underdiagnosis and undertreatment remain common. Diagnostic complexity is driven by atypical presentations, comorbidities, overlapping COPD features, and limitations of standard diagnostic criteria. Patient-related barriers include low health literacy, poor inhaler technique, symptom misattribution, psychological comorbidity, and limited social support. Access to biologic therapies remains uneven, and precision medicine approaches for older adults are lacking. Asthma in older adults is an important and underrecognized public health issue. Better awareness, age-adapted diagnostic protocols, improved inhaler education, and more integrated management of comorbidities are needed to improve outcomes and quality of life.